Slovenian recommendations for parvovirus B19 infection in pregnancy

Clicks: 396
ID: 93047
2018
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #5 of 7 articles by views in zdravniški vestnik

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Parvovirus B19 (B19V) causes a mild disease called erythema infectiosum, also known as the fifh disease that affects mostly children and young adults. The virus can be transferred to the fetus during pregnancy in 31 to 51 % of the cases and can cause severe anaemia, non-immune hydrops fetalis or fetal death due to inhibition of erythropoiesis. It also affects the heart muscle, central nervous system, bones, and most likely can cause a subsequent arrest in children’s neurological development. It is estimated that 25–45 % of pregnant women are seronegative with a high risk of infection during pregnancy. A B19V infection in pregnant women is determined by detecting specific IgM and IgG antibodies, and in case of doubt, by using PCR method to detect viral DNA. Fetal infection with B19V is confirmed by detecting viral DNA in the amniotic fluid. In the case of either a suspected or confirmed fetal infection we monitor the fetus by ultrasound screening in a tertiary centre. We treat the fetus with an intrauterine transfusion at the first signs of anaemia or hydrops. To prevent fresh infections with B19V during pregnancy we should raise awareness amongst women and healthcare workers about the risks it poses for the fetus. The recommendations for management of women who are exposed to, are at risk of developing, or have developed B19V infection in pregnancy are published in this article.
Reference Key
avgustin2018slovenianzdravniski Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Avguštin, Nina Osvald;Sršen, Tanja Premru;Stritar, Barbara Šajina;Mujezinović, Faris;
Journal zdravniški vestnik
Year 2018
DOI
DOI not found
URL
http://vestnik.szd.si/index.php/ZdravVest/article/view/2618
Keywords
Pharmacy and materia medica Therapeutics. Pharmacology Medicine surgery general works neoplasms. tumors. oncology. including cancer and carcinogens economics as a science education (general) special aspects of education insurance engineering machinery, tools, and implements technological innovations. automation

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.